Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Abraham

Showing results (191-200 of 222) with videos related to

Pageof 23
Sort By:
Therapeutic Advances in Neurological Disorders|June 23, 2011
Symptomatic therapy in multiple sclerosisTeresa C Frohman, Wanda Castro, Anjali Shah, et al.
Ecancermedicalscience|April 29, 2021
Neoadjuvant chemotherapy with biosimilar trastuzumab in human epidermal growth factor receptor 2 overexpressed non-metastatic breast cancer: patterns of use and clinical outcomes in IndiaAnjana Joel, Josh Thomas Georgy, Divya Bala Thumaty, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|January 20, 2021
Does Baseline PTH Influence Recovery of Bone Mineral Density, Trabecular Bone Score and Bone Turnover Markers? A Prospective Study Following Curative PArathyroidectomy in Primary HyperparathyroidismShrinath Shetty, Kripa Elizabeth Cherian, Sahana Shetty, et al.
Clinical Oral Investigations|April 8, 2015
Downregulation of CRNN gene and genomic instability at 1q21.3 in oral squamous cell carcinomaIman Salahshourifar, Vui King Vincent-Chong, Hong-Yun Chang, et al.
Plos One|April 7, 2017
Genome wide profiling in oral squamous cell carcinoma identifies a four genetic marker signature of prognostic significanceVui King Vincent-Chong, Iman Salahshourifar, Kar Mun Woo, et al.
Oncogene|November 15, 2019
Context-dependent activation of SIRT3 is necessary for anchorage-independent survival and metastasis of ovarian cancer cellsYeon Soo Kim, Piyushi Gupta Vallur, Victoria M Jones, et al.
Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association|May 14, 2019
m-Health for Early Detection of Oral Cancer in Low- and Middle-Income CountriesNabihah Haron, Rosnah Binti Zain, Anand Ramanathan, et al.
International Journal of Medical Sciences|December 15, 2015
Collagen Triple Helix Repeat Containing-1 (CTHRC1) Expression in Oral Squamous Cell Carcinoma (OSCC): Prognostic Value and Clinico-Pathological ImplicationsChia Ee Lee, Vui King Vincent-Chong, Anand Ramanathan, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|July 5, 2017
Effective encapsulation and biological activity of phosphorylated chemotherapeutics in calcium phosphosilicate nanoparticles for the treatment of pancreatic cancerWelley S Loc, Samuel S Linton, Zachary R Wilczynski, et al.
Human Vaccines & Immunotherapeutics|September 8, 2018
In vitro evaluation of dual-antigenic PV1 peptide vaccine in head and neck cancer patientsSan Jiun Chai, Sammuel Chee Yong Fong, Chai Phei Gan, et al.
Pageof 23

Showing results (191-200 of 222) with videos related to

Sort By:
Pageof 23
Therapeutic Advances in Neurological Disorders|June 23, 2011
Symptomatic therapy in multiple sclerosisTeresa C Frohman, Wanda Castro, Anjali Shah, et al.
Ecancermedicalscience|April 29, 2021
Neoadjuvant chemotherapy with biosimilar trastuzumab in human epidermal growth factor receptor 2 overexpressed non-metastatic breast cancer: patterns of use and clinical outcomes in IndiaAnjana Joel, Josh Thomas Georgy, Divya Bala Thumaty, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|January 20, 2021
Does Baseline PTH Influence Recovery of Bone Mineral Density, Trabecular Bone Score and Bone Turnover Markers? A Prospective Study Following Curative PArathyroidectomy in Primary HyperparathyroidismShrinath Shetty, Kripa Elizabeth Cherian, Sahana Shetty, et al.
Clinical Oral Investigations|April 8, 2015
Downregulation of CRNN gene and genomic instability at 1q21.3 in oral squamous cell carcinomaIman Salahshourifar, Vui King Vincent-Chong, Hong-Yun Chang, et al.
Plos One|April 7, 2017
Genome wide profiling in oral squamous cell carcinoma identifies a four genetic marker signature of prognostic significanceVui King Vincent-Chong, Iman Salahshourifar, Kar Mun Woo, et al.
Oncogene|November 15, 2019
Context-dependent activation of SIRT3 is necessary for anchorage-independent survival and metastasis of ovarian cancer cellsYeon Soo Kim, Piyushi Gupta Vallur, Victoria M Jones, et al.
Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association|May 14, 2019
m-Health for Early Detection of Oral Cancer in Low- and Middle-Income CountriesNabihah Haron, Rosnah Binti Zain, Anand Ramanathan, et al.
International Journal of Medical Sciences|December 15, 2015
Collagen Triple Helix Repeat Containing-1 (CTHRC1) Expression in Oral Squamous Cell Carcinoma (OSCC): Prognostic Value and Clinico-Pathological ImplicationsChia Ee Lee, Vui King Vincent-Chong, Anand Ramanathan, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|July 5, 2017
Effective encapsulation and biological activity of phosphorylated chemotherapeutics in calcium phosphosilicate nanoparticles for the treatment of pancreatic cancerWelley S Loc, Samuel S Linton, Zachary R Wilczynski, et al.
Human Vaccines & Immunotherapeutics|September 8, 2018
In vitro evaluation of dual-antigenic PV1 peptide vaccine in head and neck cancer patientsSan Jiun Chai, Sammuel Chee Yong Fong, Chai Phei Gan, et al.
Pageof 23